![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 31/506 | (2006.01) |
A61K 9/50 | (2006.01) | ||
C07D 209/34 | (2006.01) | ||
A61P 27/06 | (2006.01) | ||
A61K 9/00 | (2006.01) | ||
A61K 31/496 | (2006.01) |
(11) | Number of the document | 3463315 |
(13) | Kind of document | T |
(96) | European patent application number | 17807296.3 |
Date of filing the European patent application | 2017-05-26 | |
(97) | Date of publication of the European application | 2019-04-10 |
(45) | Date of publication and mention of the grant of the patent | 2023-06-14 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2017/034795 |
Date | 2017-05-26 |
(87) | Number | WO 2017/210132 |
Date | 2017-12-07 |
(30) | Number | Date | Country code |
201662344870 P | 2016-06-02 | US | |
201662344878 P | 2016-06-02 | US |
(72) |
NI, Jinsong , US
YANG, Rong , US
|
(73) |
ADS Therapeutics LLC ,
15615 Alton Parkway, Suite 450, Irvine, CA 92618-3308,
US
|
(54) | COMPOSITIONS AND METHODS OF USING NINTEDANIB FOR TREATING OCULAR DISEASES WITH ABNORMAL NEOVASCULARIZATION |
COMPOSITIONS AND METHODS OF USING NINTEDANIB FOR TREATING OCULAR DISEASES WITH ABNORMAL NEOVASCULARIZATION |